A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients

Figure 6

Biological process (BP), cellular component (CC), and molecular function (MF) analysis between different riskscore genes. (a, b) Typical results of KEGG analyses (a, c) and GO (b, d) in the TCGA cohort. (c, d) Results of KEGG analyses and GO in the ICGC cohort. The pink rectangles represent the overlap of immune-related pathways in the TCGA and ICGC cohorts.

(a)

(b)

(c)

(d)